Cargando…

Inhibiting the urokinase‐type plasminogen activator receptor system recovers STZ‐induced diabetic nephropathy

The urokinase‐type plasminogen activator (uPA) receptor (uPAR) participates to the mechanisms causing renal damage in response to hyperglycaemia. The main function of uPAR in podocytes (as well as soluble uPAR ‐(s)uPAR‐ from circulation) is to regulate podocyte function through αvβ3 integrin/Rac‐1....

Descripción completa

Detalles Bibliográficos
Autores principales:	Dal Monte, Massimo, Cammalleri, Maurizio, Pecci, Valeria, Carmosino, Monica, Procino, Giuseppe, Pini, Alessandro, De Rosa, Mario, Pavone, Vincenzo, Svelto, Maria, Bagnoli, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349167/ https://www.ncbi.nlm.nih.gov/pubmed/30426662 http://dx.doi.org/10.1111/jcmm.14004

Ejemplares similares

The urokinase‐type plasminogen activator system as drug target in retinitis pigmentosa: New pre‐clinical evidence in the rd10 mouse model
por: Cammalleri, Maurizio, et al.
Publicado: (2019)

Diabetic Retinopathy in the Spontaneously Diabetic Torii Rat: Pathogenetic Mechanisms and Preventive Efficacy of Inhibiting the Urokinase-Type Plasminogen Activator Receptor System
por: Cammalleri, Maurizio, et al.
Publicado: (2017)

β(3) adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function
por: Procino, Giuseppe, et al.
Publicado: (2016)

Activation of the Thiazide-Sensitive Sodium-Chloride Cotransporter by Beta3-Adrenoreceptor in the Distal Convoluted Tubule
por: Milano, Serena, et al.
Publicado: (2021)

β3‐Adrenoceptor, a novel player in the round‐trip from neonatal diseases to cancer: Suggestive clues from embryo
por: Filippi, Luca, et al.
Publicado: (2021)

The uPAR System as a Potential Therapeutic Target in the Diseased Eye
por: Cammalleri, Maurizio, et al.
Publicado: (2019)

Further Evidence on Efficacy of Diet Supplementation with Fatty Acids in Ocular Pathologies: Insights from the EAE Model of Optic Neuritis
por: Locri, Filippo, et al.
Publicado: (2018)

Decoupling Oxygen Tension From Retinal Vascularization as a New Perspective for Management of Retinopathy of Prematurity. New Opportunities From β-adrenoceptors
por: Filippi, Luca, et al.
Publicado: (2022)

Potential role of the methylation of VEGF gene promoter in response to hypoxia in oxygen‐induced retinopathy: beneficial effect of the absence of AQP4
por: Pisani, Francesco, et al.
Publicado: (2017)

UPARANT is an effective antiangiogenic agent in a mouse model of rubeosis iridis
por: Locri, Filippo, et al.
Publicado: (2019)

Urokinase-type plasminogen activator receptor in IgA nephropathy
por: Ahn, Shin-Young, et al.
Publicado: (2014)

Novel Insights into Beta 2 Adrenergic Receptor Function in the rd10 Model of Retinitis Pigmentosa
por: Cammalleri, Maurizio, et al.
Publicado: (2020)

Protective Efficacy of a Dietary Supplement Based on Forskolin, Homotaurine, Spearmint Extract, and Group B Vitamins in a Mouse Model of Optic Nerve Injury
por: Locri, Filippo, et al.
Publicado: (2019)

A Dietary Combination of Forskolin with Homotaurine, Spearmint and B Vitamins Protects Injured Retinal Ganglion Cells in a Rodent Model of Hypertensive Glaucoma
por: Cammalleri, Maurizio, et al.
Publicado: (2020)

HIF-1-Dependent Induction of β3 Adrenoceptor: Evidence from the Mouse Retina
por: Amato, Rosario, et al.
Publicado: (2022)

Gaining insight on mitigation of rubeosis iridis by UPARANT in a mouse model associated with proliferative retinopathy
por: Locri, Filippo, et al.
Publicado: (2020)

Restored retinal physiology after administration of niacin with citicoline in a mouse model of hypertensive glaucoma
por: Melecchi, Alberto, et al.
Publicado: (2023)

Role of Lamin A/C Gene Mutations in the Signaling Defects Leading to Cardiomyopathies
por: Gerbino, Andrea, et al.
Publicado: (2018)

Fatty Acids Dietary Supplements Exert Anti-Inflammatory Action and Limit Ganglion Cell Degeneration in the Retina of the EAE Mouse Model of Multiple Sclerosis
por: Dal Monte, Massimo, et al.
Publicado: (2018)

The Beta Adrenergic Receptor Blocker Propranolol Counteracts Retinal Dysfunction in a Mouse Model of Oxygen Induced Retinopathy: Restoring the Balance between Apoptosis and Autophagy
por: Cammalleri, Maurizio, et al.
Publicado: (2017)

Hypotensive Effect of Nanomicellar Formulation of Melatonin and Agomelatine in a Rat Model: Significance for Glaucoma Therapy
por: Dal Monte, Massimo, et al.
Publicado: (2020)

A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma
por: Dal Monte, Massimo, et al.
Publicado: (2020)

Effects of Topical Gabapentin on Ocular Pain and Tear Secretion
por: Cammalleri, Maurizio, et al.
Publicado: (2021)

Preventive Efficacy of an Antioxidant Compound on Blood Retinal Barrier Breakdown and Visual Dysfunction in Streptozotocin-Induced Diabetic Rats
por: Canovai, Alessio, et al.
Publicado: (2022)

Increased efficacy of dietary supplement containing wax ester-rich marine oil and xanthophylls in a mouse model of dry macular degeneration
por: Melecchi, Alberto, et al.
Publicado: (2022)

High-throughput fluorescent-based NKCC functional assay in adherent epithelial cells
por: Carmosino, Monica, et al.
Publicado: (2013)

Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update
por: Milano, Serena, et al.
Publicado: (2017)

Efficacy of a Fatty Acids Dietary Supplement in a Polyethylene Glycol-Induced Mouse Model of Retinal Degeneration
por: Cammalleri, Maurizio, et al.
Publicado: (2017)

Urokinase-type Plasminogen Activator Induces Neurorepair in the Ischemic Brain
por: Merino, Paola, et al.
Publicado: (2018)

Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy
por: Rossi, Luigi, et al.
Publicado: (2017)

In silico docking of urokinase plasminogen activator and integrins
por: Degryse, Bernard, et al.
Publicado: (2008)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)

Dietary Supplementation of Antioxidant Compounds Prevents Light-Induced Retinal Damage in a Rat Model
por: Amato, Rosario, et al.
Publicado: (2021)

Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
por: Zhu, Ran, et al.
Publicado: (2022)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

Dandelion Root Extract Induces Intracellular Ca(2+) Increases in HEK293 Cells
por: Gerbino, Andrea, et al.
Publicado: (2018)

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors
Publicado: (1987)

Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse
Publicado: (1984)

Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis
por: Lee, Ji-Hye, et al.
Publicado: (2014)

The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type
Publicado: (1986)

Cannot write session to /tmp/vufind_sessions/sess_4op8f9sauc4binkslgbbu20k8j